Related references
Note: Only part of the references are listed.Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs
Franc Llorens et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2017)
Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases
Franc Llorens et al.
ALZHEIMERS & DEMENTIA (2017)
Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease
Maria Cramm et al.
MOLECULAR NEUROBIOLOGY (2016)
Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic
Matthias Schmitz et al.
MOLECULAR NEUROBIOLOGY (2016)
Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia
Franc Llorens et al.
ALZHEIMERS & DEMENTIA (2016)
SPORADIC CREUTZFELDT-JAKOB DISEASE DIAGNOSTIC ACCURACY IS IMPROVED BY A NEW CSF ELISA 14-3-3γ ASSAY
M. J. Leitao et al.
NEUROSCIENCE (2016)
Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluid
Niels Kruse et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD
Franc Llorens et al.
JOURNAL OF NEUROLOGY (2015)
Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease
F. Llorens et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
Rapid and Sensitive RT-QuIC Detection of Human Creutzfeldt-Jakob Disease Using Cerebrospinal Fluid
Christina D. Orru et al.
MBIO (2015)
A practical guide to immunoassay method validation
Ulf Andreasson et al.
FRONTIERS IN NEUROLOGY (2015)
Diagnostic Values of Cerebrospinal Fluid T-Tau and A beta(42) using Meso Scale Discovery Assays for Alzheimer's Disease
Catherine Pan et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Increased α-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
Takashi Kasai et al.
JOURNAL OF NEUROLOGY (2014)
Cerebrospinal fluid biomarkers in Alzheimer's disease, vascular dementia and ischemic stroke patients: a critical analysis
Lisa Kaerst et al.
JOURNAL OF NEUROLOGY (2013)
Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA
Piero Parchi et al.
ACTA NEUROPATHOLOGICA (2012)
Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease
Lynne I. McGuire et al.
ANNALS OF NEUROLOGY (2012)
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
Marta del Campo et al.
BIOMARKERS IN MEDICINE (2012)
Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years
Katharina Stoeck et al.
BRAIN (2012)
Sporadic human prion diseases: molecular insights and diagnosis
Gianfranco Puoti et al.
LANCET NEUROLOGY (2012)
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
N. S. M. Schoonenboom et al.
NEUROLOGY (2012)
High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease
Yuki Matsui et al.
BMC NEUROLOGY (2011)
Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study
Michael B. Coulthart et al.
BMC NEUROLOGY (2011)
Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion
Ryuichiro Atarashi et al.
NATURE MEDICINE (2011)
Evidence that a Panel of Neurodegeneration Biomarkers Predicts Vasospasm, Infarction, and Outcome in Aneurysmal Subarachnoid Hemorrhage
Robert Siman et al.
PLOS ONE (2011)
The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review
G. Chohan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Red blood cells are the major source of alpha-synuclein in blood
Robin Barbour et al.
NEURODEGENERATIVE DISEASES (2008)
Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis
Pascual Sanchez-Juan et al.
JOURNAL OF NEUROLOGY (2007)
Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance
U. Heinemann et al.
BRAIN (2007)
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
P. Sanchez-Juan et al.
NEUROLOGY (2006)
A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease
B Van Everbroeck et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Sporadic and familial CJD: classification and characterisation
P Gambetti et al.
BRITISH MEDICAL BULLETIN (2003)
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2002)
14-3-3 testing in diagnosing Creutzfeldt-Jakob disease - A prospective study in 112 patients
AW Lemstra et al.
NEUROLOGY (2000)
Share Paper
